期刊文献+

盐酸度洛西汀的含量及其有关物质的RP-HPLC测定法 被引量:5

Determination of Duloxetine hydrochloride and its related substances by RP-HPLC
原文传递
导出
摘要 目的建立反相高效液相色谱(RP-HPLC)法测定盐酸度洛西汀含量及其有关物质。方法色谱柱为美国Diamonsil(250 mm×4.6 mm,5μm)C18反相柱;流动相为乙腈-甲醇-缓冲液=30∶30∶40,流速为1.2 ml/min;检测波长230 nm。结果盐酸度洛西汀浓度在4.8~48.0μg/ml范围内,线性关系良好,标准曲线为A=5 147.5C+4.710 7(r=0.999 8,n=7),定量下限0.5μg/ml。结论 RP-HPLC法具有快速、简便、灵敏度高、重现性好等优点,可以用于盐酸度洛西汀的含量测定及有关物质检查。 [Objective]To establish a method for determination of Duloxetine hydrochloride and its related substances by RP-HPLC.[Methods]The column was Diamonsil C18(50 mm×4.6 mm,5 μm),the mobile phase was acetonitrile: methyl alcohol: Buffer(30∶30∶40,V/V),the flow rate was 1.2 ml/min,and the detection wavelength was 230 nm.[Results]Within a concentration range of 4.8-48.0 μg/ml,the linear relationship was good.The standard curve was A=5 147.5C+4.710 7(r=0.999 8,n=7),and the lower limit of quantification was 0.5 μg/ml.[Conclusion]RP-HPLC is a rapid and convenient method with high sensitivity and good reproducibility,and it can be used in determination of Duloxetine Hydrochloride and its related substances.
出处 《职业与健康》 CAS 2013年第10期1223-1225,共3页 Occupation and Health
关键词 反相高效液相色谱法 盐酸度洛西汀 有关物质 RP-HPLC Duloxetine Hydrochloride Related substances
  • 相关文献

参考文献7

  • 1Li ZS, Jinan L, Yang Z. Comparative effectiveness in pain-related out-comes and health care utilizations between veterans with major depressivedisorder treated with duloxetine and other antidepressants : A retrospec-tive propensity score-matched comparison [ J] . Pain Practi,2012,12:374-384.
  • 2Lai CH,Wu YT. Frontal regional homogeneity increased and temporal re-gional homogeneity decreased after remission of first-episode drug-na. vemajor depressive disorder with panic disorder patients under duloxetinetherapy for 6 weeks[ J] - J Affect Disord,2012,136:453 -458.
  • 3Oakes TM, Myers AL, Marangell LB, et al. Assessment of depressivesymptoms and functional outcomes in patients with major depressive dis-order treated with duloxetine versus placebo : primary outcomes from twotrials conducted under the same protocol[ J]. Human Psychopharmacol,2012,27:47-56.
  • 4Ulu S^Elmali F. Validated spectrophotometric method for the deteimina-tion,spectroscopic characterization and thermal stmctural {malysis of du-loxetine with 1, 2-naphthoquinone-4-sulphonate [ J]. Optics Spectr,2012,112:431 -437.
  • 5Reddy P,Sreeramulu J,Naidu P,et al. Stability Indicating Fast LC forthe Simultaneous Estimation of Intermediates and Degradants (rf Duloxe-tine Hydrochloride[ J]. Chromatographia ,2010,71:95 - 100.
  • 6Zhao RK,Cheng G,Tang J,et al. Pharmacokinetics of duloxetine hydro-chloride enteric-coated tablets in healthy Chinese volunte.B : A random-ized ,open-label, single-and multiple . dose study [ J]. Clin Therapeu-tics ,2009,31 :1022 -1036.
  • 7Musenga A,Amore M, Mandrioli H. Determination of duloxetine in hu-man plasma by capillary ^ectrophoresis with laser-induced fluorescencedetection[ J]. J Chromatc^r B Analyt Technol Biomed life Sci,2009,877:1126-1132.

同被引文献25

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部